Abstract: Disclosed is a transdermal therapeutic system comprising an active agent impermeable backing layer, at least one adhesive layer comprising at least 70% by weight of at least one polysiloxane polymer, at least one tetrahydrocannabinol (THC) and at least one solubilizer, and optionally a protective layer for removal before use, a method for its preparation and its use as a medicament.

Abstract: A rheology system includes a rheometer including a lower plate and an upper plate, a manipulator including an arm, a loading end effector, a cleaning end effector, and a controller communicatively coupled to the rheometer and the manipulator, the controller including a processor and a computer readable and executable instruction set, which when executed, causes the processor to direct the manipulator to couple the loading end effector to the arm, direct the manipulator engage a specimen with the loading end effector, direct the manipulator to position the specimen on the lower plate of the rheometer, direct the upper plate to engage the specimen between the upper plate and the lower plate, direct the manipulator to couple the cleaning end effector to the arm, and direct the manipulator to engage the lower plate with the cleaning end effector.

Abstract: The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the ? opioid receptor and/or the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

Abstract: The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the ? opioid receptor and the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

Abstract: The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the ? opioid receptor and/or the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

Abstract: The invention relates to compounds that have an affinity to the ?-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.

Abstract: The invention relates to compounds that have an affinity to the ?-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.

Abstract: The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the ? opioid receptor and the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

Abstract: The invention provides methods of producing composite polymers by combining fillers with polymers in the presence of pre-formed high molecular weight polymer. Monomer polymerization can be initiated through the addition of initiators or by reactive chemical groups on the surface of the fibers. The composite materials formed possess superior mechanical properties compared to similar polymer composites made by either purely mechanical mixing or solely polymerization of monomers in the presence of the fillers.

Abstract: Grafting polymer chains onto filler particles is an established methodology for creating superior polymer composite materials. Stereocomplexation is a non-bonded interaction between polymers that leads to a crystalline form having a higher melting temperature than the non-stereocomplexed form; stereocomplexed polymers often have superior properties compared to their non-stereocomplexed constituents. The present application discloses combining grafted filler particles with matrix materials in which the grafted polymer layer forms a stereocomplex with the polymer matrix. The resulting composite materials have properties which exceed both filled polymer systems and stereocomplexed polymers.

Abstract: The invention provides methods of producing composite polymers by combining fillers with polymers in the presence of pre-formed high molecular weight polymer. Monomer polymerization can be initiated through the addition of initiators or by reactive chemical groups on the surface of the fibers. The composite materials formed possess superior mechanical properties compared to similar polymer composites made by either purely mechanical mixing or solely polymerization of monomers in the presence of the fillers.

Abstract: The invention provides methods of producing composite polymers by combining fillers with polymers in the presence of preformed high molecular weight polymer. Monomer polymerization can be initiated through the addition of initiators or by reactive chemical groups on the surface of the fibers. The composite materials formed possess superior mechanical properties compared to similar polymer composites made by either purely mechanical mixing or solely polymerization of monomers in the presence of the fillers.